U.S. Markets open in 4 hrs 4 mins

U.S. approves first pot plant-derived drug for epilepsy

The U.S. health regulator approved GW Pharmaceuticals Plc.'s epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis.